Non-ownership Filings
| Block listing Interim Review | Jun. 02, 2025 |
| Total Voting Rights | Jun. 02, 2025 |
| Imfinzi recommended in EU for bladder cancer | May. 27, 2025 |
| Acquisition of EsoBiotec completed | May. 20, 2025 |
| Imfinzi improved DFS in early bladder cancer | May. 09, 2025 |
| Enhertu improved pCR in early-stage breast cancer | May. 07, 2025 |
| Calquence combination approved in EU for 1L MCL | May. 06, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | May. 23, 2025 |
| Director/PDMR Shareholding | May. 01, 2025 |
| Holding(s) in Company | Mar. 12, 2025 |
| Director/PDMR Shareholding | Mar. 07, 2025 |
| Director/PDMR Shareholding | Mar. 06, 2025 |
| Director/PDMR Shareholding | Mar. 05, 2025 |
| Holding(s) in Company | Feb. 18, 2025 |